Humasis Co. Ltd. (KOSDAQ:205470)
South Korea
· Delayed Price · Currency is KRW 1,341.00
+21.00 (1.59%)
May 13, 2025, 3:30 PM KST
Humasis Revenue
In the year 2024, Humasis had annual revenue of 25.41B KRW with 83.79% growth. Humasis had revenue of 11.91B in the quarter ending December 31, 2024, with 288.68% growth.
Revenue
25.41B
Revenue Growth
+83.79%
P/S Ratio
5.97
Revenue / Employee
357.93M
Employees
71
Market Cap
151.74B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| HLB Co., Ltd. | 68.13B |
| SK Biopharmaceuticals | 547.60B |
| PharmaResearch | 350.12B |
| Peptron | 3.15B |